Updated Jul 16, 2026
Goodman Tony is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.
Tony Goodman is the Chief Operating Officer of Adial Pharmaceuticals, Inc., a company focused on developing treatments for addiction and related disorders. His role involves overseeing the company's operational strategies and ensuring the effective execution of its business plans.
| Role | Chief Operating Officer, Director |
|---|---|
| Notability | 10/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-04-09 | ADIL | ADIAL PHARMACEUTICALS, INC. | A — Grant or award | 26.5K | $0.00 |
Tony Goodman is the Chief Operating Officer of Adial Pharmaceuticals, Inc., a company focused on developing treatments for addiction and related disorders. His role involves overseeing the company's operational strategies and ensuring the effective execution of its business plans.…
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Goodman Tony profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.